Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 5R44MD012279 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| dfusion Inc | INDUSTRY |
| Portland State University | OTHER |
| National Institute on Minority Health and Health Disparities (NIMHD) | NIH |
Not provided
Not provided
Not provided
Not provided
The study is a 2-arm cluster randomized controlled trial to be conducted with 450 trans women to assess the effectiveness of the Trans Women Connected mobile app. Those in the treatment arm will be provided with the Trans Women Connected app, to be downloaded to their own device, and asked to use it during a month period. Those in the control arm will be asked to download a general health app and use it during a month period. Participants will complete brief online surveys at baseline, immediately following the app-use period (1-month post baseline), and at 3- and 6-months following baseline. The baseline and follow-up assessments will collect data on demographic characteristics, measures related to our primary and secondary outcomes, and psychosocial measures. The primary outcome measures are self-reported sexually transmitted infection (STI)/HIV testing and sex without a condom, with secondary measures including sexual risk behaviors, health care visits, perceived social support/connectedness, pre-exposure prophylaxis (PrEP) use, self-efficacy in negotiation/communication, and comfort with gender identity and appearance. In addition, process data, such as forum content, and usage data will be collected and analyzed.
A 2-arm cluster randomized controlled trial will be conducted with 450 trans women to assess the effectiveness of the Trans Women Connected mobile app. The Trans Women Connected intervention will address the unique needs of transgender women and the lack of evidence-based, transgender-specific HIV prevention. It is a mobile app delivered sexual health promotion program that engages transgender women through a strengths-based approach to HIV prevention and sexual health that uses the power of social networks to identify and encourage protective factors that support the health of transgender women. This approach recognizes the social and structural barriers that transgender women face. In the context of these barriers, which include stigma and discrimination in a number of interconnected spheres, individually-focused behavioral interventions are insufficient. This intervention takes a more comprehensive approach that intentionally targets community strengths and challenges. The mobile app will include more than 30 interactive activities including resource maps, PrEP content, post-exposure prophylaxis (PEP) content, and communication forums.
To be eligible, participants will be required to self-identify as transgender women; report having had 2 or more sexual partners in the past 90 days with at least one of those partners having a penis; be age 18-49 at baseline; own a smartphone; and reside in any state in the United States. Those in the treatment arm will be provided with the Trans Women Connected app, to be downloaded to their own device, and asked to use it during a month period. Those in the control arm will be asked to download a general health app and use it during a month period. Participants will complete brief online surveys at baseline, immediately following the app-use period (1-month post baseline), and at 3- and 6-months following baseline.
Participants will be recruited using a variety of methods, including: 1) Regional transwomen recruitment/retention specialists who are responsible for facilitating recruitment in their regions, addressing study questions, and maintaining connections with each participant to support study engagement; 2) Organizations. Organizations from across the U.S., at least one per state, that serve transgender women will be approached to help recruit participants through social media and in-person. 3) Google Adwords. Placing study advertisements on Google based on keyword for participant recruitment has been shown to be effective. 4) Social Media Advertising including targeted advertising on social media sites (Facebook/Instagram) and sponsoring study posts with social media influencers in the Transwomen community. Social media advertising has been shown to be favorable in terms of its cost-effectiveness, usability, and reach, especially with hard-to-reach populations, young adults and lesbian, gay, bisexual, and transgender (LGBT) populations. 5) Participant Recruitment (participants sharing information about the study within their networks). Participants will complete 4 web-based surveys and will receive $20 for baseline survey, $20 for an immediate posttest, $40 at 3-month follow up, $60 at final 6-month follow up.
Randomization. The 2-arm randomized controlled trial involves randomizing individual participants using an equal allocation (allocation ratio 1:1) to receive the full TWC app or an attention control app. Participants were randomized after completing their baseline surveys using the randomizer feature of Qualtrics.
Data Collection. Participants will be surveyed at 4 time points. 1) before randomization, 2) after using the mobile app for 1 month, 3) three months after completion of the baseline, and 4) six months after completion of the baseline. Surveys will be completed online through emailed or texted links. Data will also be collected through the apps. This includes usage data, such as what activities participants used and for how long, and process data, which includes content on the communication forum, text answers in the app, and visual content such as vision boards. Participants will receive an incentive of $20 for the baseline and immediate post-intervention survey, $40 for the 3-month follow up survey, and $60 for the 6 month follow up survey.
Study Hypotheses. Primary Hypotheses 1 (representing sexual health risk reduction through engagement in care 1) Women in the intervention group will report more STI testing (higher rates of STI testing in the prior 90 days) than the comparison group. Primary Hypotheses 2, women in the intervention group will report fewer acts of receptive condomless anal intercourse or condomless vaginal intercourse. Secondary Hypotheses (representing other important sexual health risk, and psychosocial outcomes):1) Participants in the intervention group will report reduced sexual risk taking including fewer acts of receptive condomless anal intercourse or condomless vaginal intercourse; greater use of condom use at last intercourse (receptive anal or vaginal); and increased use of PrEP for those that are HIV- 2) Participants in the intervention group will engage more with proactive health care and report more health care visits. 3) Participants in the treatment group will report more connectedness with other transgender women, including perceived social support and engagement with a mentor. 4) Participants in the intervention group will report greater efficacy in having safer sex and in communication both with partners and health care workers. 5) Those in the treatment group will have greater acceptance of their gender identity/comfort with gender identity.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| TWC App | Experimental | The intervention is a mobile app delivered sexual health promotion program designed specifically for transgender women. The mobile app includes 42 interactive activities plus resource maps, opportunities for mentoring, and communication forums for connecting with other transgender women. |
|
| General Health App | Active Comparator | An alternate mobile app (TWC COVID only) designed specifically for transgender women. The mobile app includes 7 interactive activities focused on COVID and COVID resources. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Trans Women Connected | Behavioral | The intervention will address the unique needs of transgender women and the lack of evidence-based, transgender-specific HIV prevention. It is a mobile app delivered sexual health promotion program that engages transgender women through a strengths based approach to HIV prevention and sexual health that uses the power of social networks to identify and encourage protective factors that support the health of transgender women. This approach recognizes the social and structural barriers that transgender women face. In the context of these barriers, which include stigma and discrimination in a number of interconnected spheres, individually-focused behavioral interventions are insufficient. This intervention takes a more comprehensive approach that intentionally targets community strengths and challenges. The mobile app will include more than 30 interactive activities including resource maps, PrEP/PEP content, and communication forums. |
| Measure | Description | Time Frame |
|---|---|---|
| Self-reported HIV or STI Testing in Past 3 Months | Participant reported having tested for HIV or STI in the past 3 months | 3-months post intervention |
| Self-reported HIV or STI Testing in Past 3 Months | Participant reported having tested for HIV or STI in the past 3 months | 6-months post intervention |
| Receptive Condomless Anal Intercourse or Condomless Vaginal Intercourse in Past 3 Months | Participant reported having had receptive anal intercourse without a condom or receptive vaginal intercourse without a condom in the past 3 months | 3-months post intervention |
| Receptive Condomless Anal Intercourse or Condomless Vaginal Intercourse in Past 3 Months | Participant reported having had receptive anal intercourse without a condom or receptive vaginal intercourse without a condom in the past 3 months | 6-months post intervention |
| Measure | Description | Time Frame |
|---|---|---|
| Use of a Condom at Last Receptive Anal Intercourse or Vaginal Intercourse | Participant reported using a condom at last receptive anal intercourse or vaginal intercourse | 3-month post intervention |
| Use of a Condom at Last Receptive Anal Intercourse or Vaginal Intercourse |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Anyone not meeting inclusion criteria
All participants must identify as transgender women.
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Tamara Kuhn | dfusion Inc | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| ETR | Scotts Valley | California | 95066 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 16235135 | Background | Ramirez-Valles J, Heckathorn DD, Vazquez R, Diaz RM, Campbell RT. From networks to populations: the development and application of respondent-driven sampling among IDUs and Latino gay men. AIDS Behav. 2005 Dec;9(4):387-402. doi: 10.1007/s10461-005-9012-3. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | TWC App | The intervention is a mobile app delivered sexual health promotion program designed specifically for transgender women. The mobile app includes 42 interactive activities plus resource maps, opportunities for mentoring, and communication forums for connecting with other transgender women. |
| FG001 | General Health App | An alternate mobile app (TWC COVID only) was designed specifically for transgender women. The mobile app includes 7 interactive activities focused on COVID and COVID resources. |
| Title | Milestones | Reasons Not Completed | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | TWC App | The intervention is a mobile app delivered sexual health promotion program designed specifically for transgender women. The mobile app includes 42 interactive activities plus resource maps, opportunities for mentoring, and communication forums for connecting with other transgender women. |
| BG001 |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | 5 participants did not report age at baseline. 4 control participants and 1 treatment participant. |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Self-reported HIV or STI Testing in Past 3 Months | Participant reported having tested for HIV or STI in the past 3 months | All participants with baseline and 3-month follow-up survey. | Posted | Count of Participants | Participants | 3-months post intervention |
|
Entire study period (consent through 6 month follow-up), approximately 7 months.
Used "clinicaltrials.gov" definitions.
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | TWC App | The intervention is a mobile app delivered sexual health promotion program designed specifically for transgender women. The mobile app includes 42 interactive activities plus resource maps, opportunities for mentoring, and communication forums for connecting with other transgender women. |
Not provided
Not provided
Relatively brief follow-up period (6 months) limits insights on longer-term impacts; some participants reported struggles with app download (affected both conditions), which may be linked to lack of more robust treatment effects; COVID impacted study progression and likely impacted behavior related to some outcomes (e.g., HIV/STI testing due to service shifts affected by COVID).
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Tamara Kuhn, Vice President & Research Scientist | dfusion, Inc | 831-222-5003 | tamara.kuhn@dfusioninc.com |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Sep 26, 2022 | Dec 7, 2023 | Prot_SAP_000.pdf |
Not provided
| ID | Term |
|---|---|
| D000163 | Acquired Immunodeficiency Syndrome |
| D001519 | Behavior |
| D012749 | Sexually Transmitted Diseases |
| ID | Term |
|---|---|
| D015658 | HIV Infections |
| D000086982 | Blood-Borne Infections |
| D003141 | Communicable Diseases |
| D007239 | Infections |
Not provided
Not provided
This is a two arm randomized controlled trial.
Implementation. After randomization, participants will be granted access to download and install their respective Trans Women Connected mobile apps (intervention or attention control).
Not provided
Not provided
Participants are randomly assigned to their condition without being made aware of their assigned condition. Each condition downloads and uses an app so study activities are similar reducing the likelihood participants will be aware of their assigned condition.
Not provided
|
| General Health App | Behavioral | The control group will download a mobile app that addresses COVID and provides COVID resources. |
|
Participant reported using a condom at last receptive anal intercourse or vaginal intercourse |
| 6-month post intervention |
| Health Care Visits in Past 3 Months | Average # of self-reported visits to a health care provider (of any type and by type) | 3-months post intervention |
| Health Care Visits in Past 3 Months | Average # of self-reported visits to a health care provider (of any type and by type) | 6-months post intervention |
| Mini-Medical Outcomes Study--Social Support Survey (mMOS-SS) | Perceptions of social support, mean score of 8 items measured on a five point scale (1-5). Scale range is from 1 - 5 with a higher number indicating greater perceived social support, which is a better outcome. | 1-month post intervention |
| Mini-Medical Outcomes Study--Social Support Survey (mMOS-SS) | Perceptions of social support, mean score of 8 items measured on a five point scale (1-5). Scale range is from 1 - 5 with a higher number indicating greater perceived social support, which is a better outcome. | 3-month post intervention |
| Mini-Medical Outcomes Study--Social Support Survey (mMOS-SS) | Perceptions of social support, mean score of 8 items measured on a five point scale (1-5). Scale range is from 1 - 5 with a higher number indicating greater perceived social support, which is a better outcome. | 6-month post intervention |
| Engaged as/With Mentor in Past 3 Months | Self-reported number of contacts in the past 3 months as a mentor/mentee for guidance or support | 3-months post intervention |
| Engaged as/With Mentor in Past 3 Months | Self-reported number of contacts, in the past 3 months, as a mentor/mentee for guidance or support | 6-months post intervention |
| PrEP Uptake | Self-reported uptake of PrEP among HIV since last measurement period- subsample | 1-month post intervention |
| PrEP Uptake | Self-reported uptake of PrEP among HIV since last measurement period- subsample | 3-month post intervention |
| PrEP Uptake | Self-reported uptake of PrEP among HIV since last measurement period- subsample | 6-month post intervention |
| Condom/Barrier Negotiation Self Efficacy Scale | Scale measures self-efficacy in decisions around using protective barriers during sex. Average of 8 items on a 7-point scale (1 to 7), with a range of 1 - 7, with a higher score indicating better outcomes, or greater self-efficacy | 1 month post-intervention |
| Condom/Barrier Negotiation Self Efficacy Scale | Scale measures self-efficacy in decisions around using protective barriers during sex. Average of 8 items on a 7-point scale (1 to 7), with a range of 1 - 7, with a higher score indicating better outcomes, or greater self-efficacy | 3- month post intervention |
| Condom/Barrier Negotiation Self Efficacy Scale | Scale measures self-efficacy in decisions around using protective barriers during sex. Average of 8 items on a 7-point scale (1 to 7), with a range of 1 - 7, with a higher score indicating better outcomes, or greater self-efficacy | 6-month post intervention |
| Health Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale | Sub-scale measures comfort navigating health services. Average of 5 items on a 4-point scale (1-4), with a range of 1 - 4, with a higher score indicating greater comfort navigating health services | 1-month post intervention |
| Health Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale | Sub-scale measures comfort navigating health services. Average of 5 items on a 4-point scale (1-4), with a range of 1 - 4, with a higher score indicating greater comfort navigating health services | 3-month post intervention |
| Health Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale | Sub-scale measures comfort navigating health services. Average of 5 items on a 4-point scale (1-4), with a range of 1 - 4, with a higher score indicating greater comfort navigating health services | 6- month post intervention |
| Transgender Congruence Scale (TCS) | Scale measures degree of comfort with external appearance as it relates to gender identity. Average of 12 items on a 5-point scale, with a range of 1 - 5, with a higher score indicating a perception that their appearance reflects their chosen gender identity | 1-month post intervention |
| Transgender Congruence Scale (TCS) | Scale measures degree of comfort with external appearance as it relates to gender identity. Average of 12 items on a 5-point scale, with a range of 1 - 5, with a higher score indicating a perception that their appearance reflects their chosen gender identity | 3-month post intervention |
| Transgender Congruence Scale (TCS) | Scale measures degree of comfort with external appearance as it relates to gender identity. Average of 12 items on a 5-point scale, with a range of 1 - 5, with a higher score indicating a perception that their appearance reflects their chosen gender identity | 6-month post intervention |
| Trans Women Connected Satisfaction Survey | Scale measures participants' reactions to the app. Average of 3 items on a 5-point scale with a range of 1 to 5 with a higher score indicating greater levels of satisfaction with the app. | 1-month post intervention |
| General Health App |
An alternate mobile app (TWC COVID only) was designed specifically for transgender women. The mobile app includes 7 interactive activities focused on COVID and COVID resources. |
| BG002 | Total | Total of all reporting groups |
| Mean |
| Standard Deviation |
| years |
|
| Sex/Gender, Customized | Number | participants |
|
| Ethnicity (NIH/OMB) | Count of Participants | Participants |
|
| Race (NIH/OMB) | Count of Participants | Participants |
|
| Region of Enrollment | Number | participants |
|
| Sexual orientation | Count of Participants | Participants |
|
| STI test in past 3 months | Count of Participants | Participants |
|
| HIV test in past 3 months | Count of Participants | Participants |
|
| Receptive sex without condom in past 3 months | Count of Participants | Participants |
|
|
|
|
| Primary | Self-reported HIV or STI Testing in Past 3 Months | Participant reported having tested for HIV or STI in the past 3 months | All participants who completed baseline and 6-month follow-up surveys. | Posted | Count of Participants | Participants | 6-months post intervention |
|
|
|
|
| Primary | Receptive Condomless Anal Intercourse or Condomless Vaginal Intercourse in Past 3 Months | Participant reported having had receptive anal intercourse without a condom or receptive vaginal intercourse without a condom in the past 3 months | All participants who completed baseline and 3-month follow-up surveys. | Posted | Count of Participants | Participants | 3-months post intervention |
|
|
|
|
| Primary | Receptive Condomless Anal Intercourse or Condomless Vaginal Intercourse in Past 3 Months | Participant reported having had receptive anal intercourse without a condom or receptive vaginal intercourse without a condom in the past 3 months | All participants completing baseline and 6-month follow up survey. | Posted | Count of Participants | Participants | 6-months post intervention |
|
|
|
|
| Secondary | Use of a Condom at Last Receptive Anal Intercourse or Vaginal Intercourse | Participant reported using a condom at last receptive anal intercourse or vaginal intercourse | All participants who completed baseline and 3-month follow-up surveys. | Posted | Count of Participants | Participants | 3-month post intervention |
|
|
|
|
| Secondary | Use of a Condom at Last Receptive Anal Intercourse or Vaginal Intercourse | Participant reported using a condom at last receptive anal intercourse or vaginal intercourse | All participants who completed baseline and 6-month follow-up surveys. | Posted | Count of Participants | Participants | 6-month post intervention |
|
|
|
|
| Secondary | Health Care Visits in Past 3 Months | Average # of self-reported visits to a health care provider (of any type and by type) | All participants completing baseline and 3-month follow-up surveys. | Posted | Mean | Standard Deviation | Number of visits | 3-months post intervention |
|
|
|
|
| Secondary | Health Care Visits in Past 3 Months | Average # of self-reported visits to a health care provider (of any type and by type) | All participants completing baseline and 6-month follow-up surveys. | Posted | Mean | Standard Deviation | Number of visits | 6-months post intervention |
|
|
|
|
| Secondary | Mini-Medical Outcomes Study--Social Support Survey (mMOS-SS) | Perceptions of social support, mean score of 8 items measured on a five point scale (1-5). Scale range is from 1 - 5 with a higher number indicating greater perceived social support, which is a better outcome. | All participants completing baseline and 1-month follow-up surveys. | Posted | Mean | Standard Deviation | score on a scale | 1-month post intervention |
|
|
|
|
| Secondary | Mini-Medical Outcomes Study--Social Support Survey (mMOS-SS) | Perceptions of social support, mean score of 8 items measured on a five point scale (1-5). Scale range is from 1 - 5 with a higher number indicating greater perceived social support, which is a better outcome. | All participants completing baseline and 3-month follow-up surveys. | Posted | Mean | Standard Deviation | score on a scale | 3-month post intervention |
|
|
|
|
| Secondary | Mini-Medical Outcomes Study--Social Support Survey (mMOS-SS) | Perceptions of social support, mean score of 8 items measured on a five point scale (1-5). Scale range is from 1 - 5 with a higher number indicating greater perceived social support, which is a better outcome. | All participants completing baseline and 6-month follow-up surveys. | Posted | Mean | Standard Deviation | score on a scale | 6-month post intervention |
|
|
|
|
| Secondary | Engaged as/With Mentor in Past 3 Months | Self-reported number of contacts in the past 3 months as a mentor/mentee for guidance or support | Participants completing baseline and 3-month follow-up surveys. | Posted | Mean | Standard Deviation | Number of mentee/mentor contacts | 3-months post intervention |
|
|
|
|
| Secondary | Engaged as/With Mentor in Past 3 Months | Self-reported number of contacts, in the past 3 months, as a mentor/mentee for guidance or support | Participants completing baseline and 6-month follow-up surveys. | Posted | Mean | Standard Deviation | Number of mentor/mentee contacts | 6-months post intervention |
|
|
|
|
| Secondary | PrEP Uptake | Self-reported uptake of PrEP among HIV since last measurement period- subsample | Participants completing baseline and 1-month follow-up survey. | Posted | Count of Participants | Participants | 1-month post intervention |
|
|
|
|
| Secondary | PrEP Uptake | Self-reported uptake of PrEP among HIV since last measurement period- subsample | Participants completing baseline and 3-month follow-up surveys. | Posted | Count of Participants | Participants | 3-month post intervention |
|
|
|
|
| Secondary | PrEP Uptake | Self-reported uptake of PrEP among HIV since last measurement period- subsample | Participants completing baseline and 6-month follow-up survey. | Posted | Count of Participants | Participants | 6-month post intervention |
|
|
|
|
| Secondary | Condom/Barrier Negotiation Self Efficacy Scale | Scale measures self-efficacy in decisions around using protective barriers during sex. Average of 8 items on a 7-point scale (1 to 7), with a range of 1 - 7, with a higher score indicating better outcomes, or greater self-efficacy | Participants completing baseline and 1-month follow-up surveys. | Posted | Mean | Standard Deviation | score on a scale | 1 month post-intervention |
|
|
|
|
| Secondary | Condom/Barrier Negotiation Self Efficacy Scale | Scale measures self-efficacy in decisions around using protective barriers during sex. Average of 8 items on a 7-point scale (1 to 7), with a range of 1 - 7, with a higher score indicating better outcomes, or greater self-efficacy | Participants completing baseline and 3-month follow-up surveys. | Posted | Mean | Standard Deviation | score on a scale | 3- month post intervention |
|
|
|
|
| Secondary | Condom/Barrier Negotiation Self Efficacy Scale | Scale measures self-efficacy in decisions around using protective barriers during sex. Average of 8 items on a 7-point scale (1 to 7), with a range of 1 - 7, with a higher score indicating better outcomes, or greater self-efficacy | Participants completing baseline and 6-month follow-up surveys. | Posted | Mean | Standard Deviation | score on a scale | 6-month post intervention |
|
|
|
|
| Secondary | Health Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale | Sub-scale measures comfort navigating health services. Average of 5 items on a 4-point scale (1-4), with a range of 1 - 4, with a higher score indicating greater comfort navigating health services | Participants completing baseline and 1-month follow-up surveys. | Posted | Mean | Standard Deviation | score on a scale | 1-month post intervention |
|
|
|
|
| Secondary | Health Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale | Sub-scale measures comfort navigating health services. Average of 5 items on a 4-point scale (1-4), with a range of 1 - 4, with a higher score indicating greater comfort navigating health services | Participants completing baseline and 3-month follow-up surveys. | Posted | Mean | Standard Deviation | score on a scale | 3-month post intervention |
|
|
|
|
| Secondary | Health Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale | Sub-scale measures comfort navigating health services. Average of 5 items on a 4-point scale (1-4), with a range of 1 - 4, with a higher score indicating greater comfort navigating health services | Participants completing baseline and 6-month follow-up surveys. | Posted | Mean | Standard Deviation | score on a scale | 6- month post intervention |
|
|
|
|
| Secondary | Transgender Congruence Scale (TCS) | Scale measures degree of comfort with external appearance as it relates to gender identity. Average of 12 items on a 5-point scale, with a range of 1 - 5, with a higher score indicating a perception that their appearance reflects their chosen gender identity | Participants completing baseline and 1-month follow-up surveys. | Posted | Mean | Standard Deviation | score on a scale | 1-month post intervention |
|
|
|
|
| Secondary | Transgender Congruence Scale (TCS) | Scale measures degree of comfort with external appearance as it relates to gender identity. Average of 12 items on a 5-point scale, with a range of 1 - 5, with a higher score indicating a perception that their appearance reflects their chosen gender identity | Participants completing baseline and 3-month follow-up surveys. | Posted | Mean | Standard Deviation | score on a scale | 3-month post intervention |
|
|
|
|
| Secondary | Transgender Congruence Scale (TCS) | Scale measures degree of comfort with external appearance as it relates to gender identity. Average of 12 items on a 5-point scale, with a range of 1 - 5, with a higher score indicating a perception that their appearance reflects their chosen gender identity | Participants completing baseline and 6-month follow-up surveys. | Posted | Mean | Standard Deviation | score on a scale | 6-month post intervention |
|
|
|
|
| Secondary | Trans Women Connected Satisfaction Survey | Scale measures participants' reactions to the app. Average of 3 items on a 5-point scale with a range of 1 to 5 with a higher score indicating greater levels of satisfaction with the app. | Participants completing 1-month follow-up survey. | Posted | Mean | Standard Deviation | score on a scale | 1-month post intervention |
|
|
|
|
| 0 |
| 275 |
| 0 |
| 275 |
| 0 |
| 275 |
| EG001 | General Health App | An alternate mobile app (TWC COVID only) was designed specifically for transgender women. The mobile app includes 7 interactive activities focused on COVID and COVID resources. | 0 | 299 | 0 | 299 | 0 | 299 |
Not provided
Not provided
| D015229 |
| Sexually Transmitted Diseases, Viral |
| D016180 | Lentivirus Infections |
| D012192 | Retroviridae Infections |
| D012327 | RNA Virus Infections |
| D014777 | Virus Diseases |
| D012897 | Slow Virus Diseases |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D007153 | Immunologic Deficiency Syndromes |
| D007154 | Immune System Diseases |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| Unknown or Not Reported |
|
| Native Hawaiian or Other Pacific Islander |
|
| Black or African American |
|
| White |
|
| More than one race |
|
| Unknown or Not Reported |
|
| Not reported |
|
| Not reported |
|
| Not reported |
|